Archives of Neuroscience

Published by: Kowsar

Recombinant Activated Factor VII, as a Remedy for Intractable Coagulopathy Following Massive Transfusion in a Case of Giant Cranial Neurofibroma

Keyvan Tayebi Meybodi 1 , Mohammad Taghvaei 1 , Nazi Derakhshanrad 2 , Zahid Hussain Khan 2 , 3 and Hooshang Saberi 1 , 2 , *
Authors Information
1 Department of Neurosurgery, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2 Brain and Spinal Injuries Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
3 Department of Neuroanesthesiology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Neuroscience: January 01, 2015, 2 (1); e18319
  • Published Online: March 19, 2014
  • Article Type: Case Report
  • Received: February 18, 2014
  • Revised: March 16, 2014
  • DOI: 10.5812/archneurosci.18319

To Cite: Tayebi Meybodi K, Taghvaei M, Derakhshanrad N, Khan Z H, Saberi H. et al. Recombinant Activated Factor VII, as a Remedy for Intractable Coagulopathy Following Massive Transfusion in a Case of Giant Cranial Neurofibroma, Arch Neurosci. 2015 ;2(1):e18319. doi: 10.5812/archneurosci.18319.

Abstract
Copyright © 2014, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
Acknowledgements
Footnotes
References
  • 1. Gerlach R, Tolle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke. 2002; 33(6): 1618-23[PubMed]
  • 2. Beshay JE, Morgan H, Madden C, Yu W, Sarode R. Emergency reversal of anticoagulation and antiplatelet therapies in neurosurgical patients. J Neurosurg. 2010; 112(2): 307-18[DOI][PubMed]
  • 3. Sutherland CS, Hill MD, Kaufmann AM, Silvaggio JA, Demchuk AM, Sutherland GR. Recombinant factor VIIa plus surgery for intracerebral hemorrhage. Can J Neurol Sci. 2008; 35(5): 567-72[PubMed]
  • 4. Park P, Fewel ME, Garton HJ, Thompson BG, Hoff JT. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients. Neurosurgery. 2003; 53(1): 34-8[PubMed]
  • 5. Uhrig L, Blanot S, Baugnon T, Orliaguet G, Carli PA, Meyer PG. Use of recombinant activated factor VII in intractable bleeding during pediatric neurosurgical procedures. Pediatr Crit Care Med. 2007; 8(6): 576-9[PubMed]
  • 6. Veshchev I, Elran H, Salame K. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma. Med Sci Monit. 2002; 8(12)-100[PubMed]
  • 7. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358(20): 2127-37[DOI][PubMed]
  • 8. Pickard JD, Kirkpatrick PJ, Melsen T, Andreasen RB, Gelling L, Fryer T, et al. Potential role of NovoSeven in the prevention of rebleeding following aneurysmal subarachnoid haemorrhage. Blood Coagul Fibrinolysis. 2000; 11 Suppl 1-20[PubMed]
  • 9. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects. Blood Coagul Fibrinolysis. 2003; 14(5): 469-77[DOI][PubMed]
  • 10. Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage. Stroke. 2008; 39(3): 850-6[DOI][PubMed]
  • 11. Earnshaw SR, Joshi AV, Wilson MR, Rosand J. Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage. Stroke. 2006; 37(11): 2751-8[DOI][PubMed]
  • 12. Khan ZH, Soltani AE, Rahmani P. Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation. J Anesth. 2007; 21(2): 258-60[DOI][PubMed]
  • 13. Kenet G, Martinowitz U. Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors. Semin Hematol. 2008; 45(2 Suppl 1)-41[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments